SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 214 filers reported holding SAGE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,072,000 | -60.7% | 62,590 | -49.6% | 0.00% | -66.7% |
| Q4 2021 | $5,278,000 | -18.3% | 124,069 | -14.9% | 0.00% | -25.0% |
| Q3 2021 | $6,462,000 | -36.5% | 145,826 | -18.6% | 0.00% | -33.3% |
| Q2 2021 | $10,176,000 | -29.9% | 179,119 | -7.7% | 0.01% | -25.0% |
| Q1 2021 | $14,524,000 | -18.6% | 194,045 | -5.9% | 0.01% | -27.3% |
| Q4 2020 | $17,842,000 | +62.6% | 206,243 | +14.9% | 0.01% | +37.5% |
| Q3 2020 | $10,974,000 | +90.8% | 179,548 | +29.8% | 0.01% | +100.0% |
| Q2 2020 | $5,753,000 | +118.5% | 138,368 | +50.9% | 0.00% | +100.0% |
| Q1 2020 | $2,633,000 | -2.2% | 91,692 | +146.0% | 0.00% | 0.0% |
| Q4 2019 | $2,691,000 | -60.7% | 37,271 | -23.5% | 0.00% | -66.7% |
| Q3 2019 | $6,839,000 | -21.6% | 48,749 | +2.3% | 0.01% | -14.3% |
| Q2 2019 | $8,726,000 | +51.0% | 47,662 | +31.2% | 0.01% | +40.0% |
| Q1 2019 | $5,780,000 | +160.0% | 36,339 | +56.6% | 0.01% | +150.0% |
| Q4 2018 | $2,223,000 | -30.4% | 23,208 | +2.6% | 0.00% | -33.3% |
| Q3 2018 | $3,194,000 | -13.7% | 22,610 | -4.4% | 0.00% | -25.0% |
| Q2 2018 | $3,702,000 | -2.7% | 23,648 | +0.1% | 0.00% | 0.0% |
| Q1 2018 | $3,805,000 | -14.1% | 23,621 | -12.2% | 0.00% | 0.0% |
| Q4 2017 | $4,431,000 | +227.7% | 26,901 | +24.0% | 0.00% | +300.0% |
| Q3 2017 | $1,352,000 | -24.7% | 21,697 | -3.7% | 0.00% | -50.0% |
| Q2 2017 | $1,795,000 | +2.7% | 22,535 | -8.3% | 0.00% | -33.3% |
| Q1 2017 | $1,747,000 | +82.5% | 24,576 | +31.2% | 0.00% | +200.0% |
| Q4 2016 | $957,000 | -15.2% | 18,734 | -23.6% | 0.00% | -50.0% |
| Q3 2016 | $1,129,000 | +111.8% | 24,515 | +38.6% | 0.00% | +100.0% |
| Q2 2016 | $533,000 | -22.9% | 17,686 | -17.9% | 0.00% | 0.0% |
| Q1 2016 | $691,000 | +53.2% | 21,543 | +178.6% | 0.00% | 0.0% |
| Q4 2015 | $451,000 | – | 7,733 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |